Basic Principle of GDocP, Good Documentation Practices, ALCOA, ALCOA+, MHRA and Eudralex Guidlines, Effective GDocP, Common GDocP errors, Benefits of GDocP, GDocP Improvement, GMP, Pharmaceutical
Good Documentation Practice (GDocP) is an essential part of the quality assurance and such, related to all aspects of GMP” this definition is based on WHO. It is a systematic procedure of preparation, reviewing, approving, issuing, recording, storing and archival of document.
In Pharma and Biotech, Weightage of the Documentation is around 70 % because as per FDA "If you do not have Document, You dint have do it."
So Good Documentation Practice is of tremendous importance for the Industry to comply any regulation like FDA, GMP or ISO.
This slide is related to Good documentation Practice in Pharmaceutical Industries. It was presented in the pharmaceutical industry (Chemidrug Industry Private Ltd.) during the training session.
Good documentation practice (commonly abbreviated GDP, recommended to abbreviate as GDocP to distinguish from "good distribution practice" also abbreviated GDP) is a term in the pharmaceutical industry to describe standards by which documents are created and maintained. While some GDocP standards are codified by various competent authorities, others are not but are considered cGMP (with emphasis on the "c", or "current"). Some competent authorities release or adopt guidelines, and they may include non-codified GDocP expectations. While authorities will inspect against these guidelines and cGMP expectations in addition to the legal requirements and make comments or observations if departures are seen. In the past years, the application of GDocP is also expanding to cosmetic industry, excipient and ingredient manufacturers.
Good Documentation Practice (GDocP) is an essential part of the quality assurance and such, related to all aspects of GMP” this definition is based on WHO. It is a systematic procedure of preparation, reviewing, approving, issuing, recording, storing and archival of document.
In Pharma and Biotech, Weightage of the Documentation is around 70 % because as per FDA "If you do not have Document, You dint have do it."
So Good Documentation Practice is of tremendous importance for the Industry to comply any regulation like FDA, GMP or ISO.
This slide is related to Good documentation Practice in Pharmaceutical Industries. It was presented in the pharmaceutical industry (Chemidrug Industry Private Ltd.) during the training session.
Good documentation practice (commonly abbreviated GDP, recommended to abbreviate as GDocP to distinguish from "good distribution practice" also abbreviated GDP) is a term in the pharmaceutical industry to describe standards by which documents are created and maintained. While some GDocP standards are codified by various competent authorities, others are not but are considered cGMP (with emphasis on the "c", or "current"). Some competent authorities release or adopt guidelines, and they may include non-codified GDocP expectations. While authorities will inspect against these guidelines and cGMP expectations in addition to the legal requirements and make comments or observations if departures are seen. In the past years, the application of GDocP is also expanding to cosmetic industry, excipient and ingredient manufacturers.
This presentation is contain information about Documentation System of Pharmaceuticals. This presentation is prepared for training on documentation in Drug International Limited (Herbal Division) Depending on WHO and ICH guideline.
ICH Q7A GMP Guidance For API .Good Documentation Practices.Why Documentation is required..? To define the method and control. GOOD DOCUMENTATION PRACTICE
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
Presentation on data integrity in Pharmaceutical Industry
Contents:
- Definition & Basics
- Criteria for integrity of laboratory data
- Regulatory Requirements
- Barriers to Complete Data
- Possible data integrity problems
- Previous observations
- FDA Warning Letters – 2013
- FDA Warning Letters – 2014
- FDA 483’s related to data integrity
- EU – Non compliance Reports
- WHO - Notice of Concern
- Summary of Data Integrity issues
- Consequences- Rebuilding Trust
- Conclusion
Good Documentation Practice (GDocP — or GRK for Good Recordkeeping) is an essential component of your overall pharmaceutical quality system (PQS) and quality risk management strategies (QRM).
new guidance on good data management was discussed and its development
recommended. The participants included national inspectors and specialists
in the various agenda topics, as well as staff of the Prequalification Team
(PQT)–Inspections
Good documentation practice
Introduction
What types of documents require to follow Good Documentation Practices?
Meaning of signature
Purpose of documentation
Basic requirements of GDP
Preparation of documents
Cancellation of GMP records
reference
• Analytical Methods
• Policies
• Batch Records
• Protocols
• Bills of Materials (BOMs)
• Test Methods
• Certificate of Analyses (CoA)
• Training
Documentation
• Certificate of Compliance (CoC)
• Logbooks
• Laboratory Notebooks
• Calibration records
• Quality records - non-conformances
- CAPAs
- internal inspection reports
- change control
This presentation is contain information about Documentation System of Pharmaceuticals. This presentation is prepared for training on documentation in Drug International Limited (Herbal Division) Depending on WHO and ICH guideline.
ICH Q7A GMP Guidance For API .Good Documentation Practices.Why Documentation is required..? To define the method and control. GOOD DOCUMENTATION PRACTICE
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
Presentation on data integrity in Pharmaceutical Industry
Contents:
- Definition & Basics
- Criteria for integrity of laboratory data
- Regulatory Requirements
- Barriers to Complete Data
- Possible data integrity problems
- Previous observations
- FDA Warning Letters – 2013
- FDA Warning Letters – 2014
- FDA 483’s related to data integrity
- EU – Non compliance Reports
- WHO - Notice of Concern
- Summary of Data Integrity issues
- Consequences- Rebuilding Trust
- Conclusion
Good Documentation Practice (GDocP — or GRK for Good Recordkeeping) is an essential component of your overall pharmaceutical quality system (PQS) and quality risk management strategies (QRM).
new guidance on good data management was discussed and its development
recommended. The participants included national inspectors and specialists
in the various agenda topics, as well as staff of the Prequalification Team
(PQT)–Inspections
Good documentation practice
Introduction
What types of documents require to follow Good Documentation Practices?
Meaning of signature
Purpose of documentation
Basic requirements of GDP
Preparation of documents
Cancellation of GMP records
reference
• Analytical Methods
• Policies
• Batch Records
• Protocols
• Bills of Materials (BOMs)
• Test Methods
• Certificate of Analyses (CoA)
• Training
Documentation
• Certificate of Compliance (CoC)
• Logbooks
• Laboratory Notebooks
• Calibration records
• Quality records - non-conformances
- CAPAs
- internal inspection reports
- change control
GxP is a set of regulations and quality guidelines formulated to ensure the safety of life
sciences products while maintaining the quality of processes throughout every stage of
manufacturing, control, storage, and distribution. The GxP standards were established by the
Food and Drug Administration for a range of compliance related activities and are recognized
as:
G: Stands for good
x: Variable
P: Stands for practices
visit : https://www.agaramtech.com/
This PDF describes demo of GMP documents kit which are primary documentation requirements. This document is intended to provide guidance regarding Good Manufacturing Practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality.
Data integrity, Pharmaceutical industry, Good Manufacturing Practice, GMP, Guidelines, Data management, DI and GMP Compliance, paper and electronic data, Archive and back up
GMP This white paper is about Electronic Batch Records (EBR) and the role they play in creating a fully digital pharmaceutical manufacturing environment that complies with 21 CFR Part 11.
This publication is about HACCP documentation kit that describes list of various documents which cover requirements of HACCP Documentation. HACCP is a tool to assess hazards and establish control systems that focus on prevention
Data Integrity in pharmaceutical laboratories is a must, the attached ppt shall help the QC members to understand and develop an integral analytical culture
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...balakrishna t
tQmlab® is the premier management system for GxP operations and for supporting regulatory submissions. It delivers transformational productivity for QA/QC labs supporting customised workflows for quality control of drugs, stability testing, product release testing and post-release quality testing.
Data Integrity in a GxP-regulated Environment - Pauwels Consulting AcademyPauwels Consulting
On Tuesday, December 6, 2016, our colleague Angelo Rossi, Senior Regulatory Compliance Consultant, gave an interesting presentation about “Data Integrity in a GxP-regulated Environment” at the Brussels Office of Pauwels Consulting in Diegem.
In his presentation, Angelo covered definitions and concepts of data integrity, the change in regulatory focus, lessons learned from recent FDA warning letters, importants highlights of regulations and guidelines. Angelo also presented a practical example of data integrity for a computerized system.
Please contact us at contact@pauwelsconsulting.com or +32 9 324 70 80 if you have any further questions regarding our consulting services in this area.
Moving to digital labeling: Journey to achieving Desired OutcomesIndegene
A step wise guide to move towards Digital Labeling. This presentation identifies the challenges and changes in the life sciences industry related to labeling and its impact. The future demands of labeling, including greater use of digital solutions, advances in language standards, increased use of mobile technologies, and a focus on simplicity and accessibility, are also discussed. The presentation concludes by emphasizing the need for companies to make their labeling operations future-ready and outlines a five-step framework for process redesign to improve labeling processes.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
What is greenhouse gasses and how many gasses are there to affect the Earth.moosaasad1975
What are greenhouse gasses how they affect the earth and its environment what is the future of the environment and earth how the weather and the climate effects.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
2. Overview
1. Guidelines
2. What is Good Documentation Practices (GDocP)?
3. Common GDocP errors
4. Examples of error
5. Benefits of GDocP
6. GDocP improvements
3. Good Documentation Practices
If it is not written down, then it didn’t happen
Document all the activity performed
Do not perform the activity if it is not on written instruction
5. What is Good Documentation Practices (GDocP)?
GDocP are those measures that collectively and individually ensure Documentation,
whether paper or electronic are following the principles of ‘ALCOA+’
Documents use for GMP purpose should comply with GDocP i.e. BMR, logbook,
Specification, SOP, Analytical method, Protocol, Qualification Doc, CofA, TA, PQR
Document handling procedure i.e Retention, Archiving, Periodic review
ALCOA + (Plus)
Attributable Consistent
Legible Complete
Contemporaneous Enduring
Original Available
Accurate
6. Good Documentation Practices
ALCOA
Attributable – clear who has capture and
document the data
Legible – readable and stay in permanent
format throughout life cycle
Contemporaneous – recorded at the time
of activity
Original – first recorded data, not ‘True
copy’
Accurate – True representation of Fact
ALCOA+
Consistent – recorded in same way
Complete – Complete pack of data
including metadata
Enduring – long lasting durable storage
(paper, electronic)
Available – Retrievable and accessible for
review
7. Effective Good Documentation Practice
Document should be designed, prepared, reviewed, distributed in Controlled manner
All Documents are approved with Effective date stamp
Easy to understand and follow, orderly fashion
Periodic review schedule and adherence to it
Hand written entries should be made in clear, legible, indelible way
Records should be made or completed at the time each action is taken and in such
a way that all significant activities concerning the manufacturer of medicinal product
are traceable
Any alteration made to the entry on a document should be signed and dated; the
alteration should permit the reading of the original information. Where appropriate,
the reason for the alteration should be recorded.
8. Common GDocP errors
Missing Entry
Incorrect Data
Calculation error
Use of uncontrolled/draft version of Document to record raw data
Poor explanation of an event
Transcription error / Poor correction
Discarding raw data due to lack of information on GMP/DI requirement
Lack of Traceability
All above common errors are directly impact on ALCOA+ principles (Eudralex Ch 4, 4.7 4.8.
4.9)
Document retention and archiving procedure
9. Example of GDocP error
Illegible Writing. Is it 29, 27, 24?
Over writing / Poor correction
Calculation Error
Use of Draft unapproved version SOP
A B =(A-B)
10. Benefit of GDocP
Compliance to Regulatory requirement
Build Confidence on System and Practice
Right information
Effectively meet ‘Right First Time’ on GDocP requirement
Ensure the Traceability
Eliminate assumption
Clear instruction to staff
Consistent quality, safety of product and performance of staff
12. GDocP Improvement
Quality on the
floor support
Address issue in
timely manner
Online Document
review
Ensure Doc
compliance
Quality
Support
Regulatory
ImpactCompliance
Document approval
Safety and Efficacy of
product
Inspection
observation